Growth hormone secretagogues have come a long way since their initial discovery over thirty years ago
Mitochondrial-targeted protective potential of elamipretide for the in vitro production of porcine embryos
More studies using genetic models such as APP null mice or -secretase beta-site APP-cleaving enzyme 1 (BACE1) null mice display a range of dysfunctions such as lowered synaptic plasticity, restricted neurogenesis and cognitive deficits (Cai et al., 2023)
These in vitro results have been further validated in murine models of malaria infection and rheumatoid arthritis, where G6PD-d or inhibition leads to less severe proinflammatory responses to stimulation marked by reduced Th1 and Th17 differentiation, decreased proatherogenic cytokines IL-1, IL-6, IL-12, and TNF, and no impact on IL-10 and TGF (classically Treg-derived) 120,121,122,123,124